Quant Healthcare Fund Regular vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹402 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹1000 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 17 Jun 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare TRI |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.39 |
Manager | Rohan Korde | Sanjeev Sharma |
ISIN Code | INF00XX01BL5 | INF966L01CG3 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Month | 2.94% | 5.49% |
6 Month | -8.47% | -12.64% |
1 Year | 15.38% | 7.36% |
3 Year | 19.44% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
6 Month | -2.01% | -2.07% |
1 Year | 0.9% | -10.93% |
3 Year | 22.14% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
1 Year | 22.47% | 55.41% |
3 Year | 18.57% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Standard Deviation | 15.667% | - |
Sharp | 0.739% | - |
Beta | 0.959% | - |
Alpha | -1.413% | - |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
---|---|---|
Name | Rohan Korde | Sanjeev Sharma |
Total AUM | ₹4626 Cr | ₹39731 Cr |
Funds Managed | 10 | 22 |
ITI Pharma and Healthcare Fund Regular - Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 7.57 | 3.06 |
Mid Cap | 31.22 | 13.75 |
Small Cap | 32.03 | 52.32 |
Large Cap | 29.19 | 30.87 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Quant Healthcare Fund Regular - Growth |
---|---|---|
Others | 8.42 | 3.06 |
Healthcare | 88.76 | 79.02 |
Basic Materials | 2.08 | - |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Energy | - | 6.71 |
Technology | - | 5.45 |
Consumer Defensive | - | 5.77 |
Top Comparisons
HDFC Arbitrage Fund - Wholesale Growth Option
3Y Returns6.82%
DSP Arbitrage Fund - Regular - Growth
3Y Returns6.7%
HSBC Multi Cap Fund - Regular - Growth
3Y Returns0%
Canara Robeco Multi Cap Fund - Regular (G)
3Y Returns0%
Franklin India Opportunities Fund - Growth
3Y Returns31.82%
Tata Quant Fund-Regular Plan-Growth
3Y Returns-100%
SBI US Specific Equity Active FoF - Regular Plan - Growth
3Y Returns13.53%
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund - Growth
3Y Returns7.31%